Another Coffin Nail for Avandia
The FDA announced that the postmarketing trial of Avandia, known as TIDE, has been placed on "partial clinical hold." No new patients may be enrolled in the trial.
The FDA announced that the postmarketing trial of Avandia, known as TIDE, has been placed on "partial clinical hold." No new patients may be enrolled in the trial.
New York Times reporter Gina Kolata, broadcasts medical hype on the front page of the paper much the way Judith Miller broadcast hype fed to her by Ahmed Chalabi and the Iraq war lobby.[1]
"The vote is an enormous blow to Avandia and GlaxoSmithKline. The vast majority of panel members voted either to withdraw the drug or to allow continued sales only if strict controls are added"
Evidence that GlaxoSmithKline concealed adverse events in their trial testing their diabetes drug, Avandia, raises the question “whether the entire system is corrupt.” “To the extent that we can’t trust the data. We are in jeopardy of giving patients the wrong drugs.” Dr. Jerome Kassirer
"Dr. Nemeroff has become the poster child for what’s wrong with academic medicine in our country." Dr. Thomas Insell, Director of the NIMH, quietly helped him get a prized position at the University of Miami.
A stunning admission of failure by major drug manufacturers who market drugs for the treatment of Alzheimer’s. "We really believe drugs are failing because we honestly don’t understand the disease."
Despite the fact that children may be at highest risk of antidepressant-induced suicide, GlaxoSmithKline is testing Paxil on 7 to 18 year old Japanese children.
The $$$ amounts–one might call them, "fees for services rendered"–reveal the truth about who wields the greatest influence on NAMI policies–and whose interests are being served by NAMI.
On March 22, 2010 the FDA recommended suspension in the use of GlaxoSMithKline’s Rotarix vaccine–to prevent rotavirus (diarrhea)–due to contamination with pig virus. Rotarix, one of two vaccines licensed in the U.S , has already been given to about 1 million U.S. children along with 30 million worldwide.
A large-scale Harvard meta-analysis published in the Journal of the American Medical Association, is the first ever to evaluate the relationship between different anticonvulsant drugs and the risk of suicide in for patients with diverse diagnoses: " the risk was derived from the specific drug that the patient was taking and not their underlying conditions."
Dr Mark Stolar, professor of clinical medicine at Northwestern: "There are very few people in whom I don’t detect bias based on where their conflicts lie.”
In response to yesterday’s AHRP Infomail (March 5) in which we informed readers that Dr. Gilbert Ross, the Medical Director of the American Council on Science and Helath (ACSH), the author of a WT OpEd (March 4, 2010), is a convicted felon, whose medical license was revoked after serving two years in prison for healthcare fraud: